组织陈列-产品详情

home > TISSUE ARRAYS > Baldder > UBD1003

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

100

CASES:

50

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

10

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

UBD1003

$295.00

Add To Collect

Description: Bladder cancer tissue array with bladder tissue, including TNM and clinical stage, 50 cases/100 cores

Details: Bladder carcinoma tissue microarray with bladder tissue, containing 34 cases of urothelial carcinoma, 3 each of squamous cell carcinoma and adenocarcinoma, plus 10 adjacent normal or cancer adjacent bladder tissue, duplicate core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

NAT(*)
AT(*)
Malignant(I)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
_ma

TISSUE ARRAYS
UBD1003

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

UBD1003

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size
A1	1	45	F	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	321.5
A2	2	45	F	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	321.5
A3	3	42	M	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	433
A4	4	42	M	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	433
A5	5	50	M	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	532
A6	6	50	M	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	532
A7	7	82	F	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	332.5
A8	8	82	F	Bladder	Low grade urothelial carcinoma	*	T1N0M0	I	Malignant	332.5
A9	9	25	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	13108
A10	10	25	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	13108
B1	11	79	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5
B2	12	79	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5
B3	13	71	M	Bladder	Low grade urothelial carcinoma	*	T2bN0M0	II	Malignant	4.532
B4	14	71	M	Bladder	Low grade urothelial carcinoma	*	T2bN0M0	II	Malignant	4.532
B5	15	56	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	650.5
B6	16	56	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	650.5
B7	17	66	M	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	332
B8	18	66	M	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	332
B9	19	55	M	Bladder	Low grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
B10	20	55	M	Bladder	Low grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
C1	21	65	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
C2	22	65	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
C3	23	45	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
C4	24	45	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
C5	25	78	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	752
C6	26	78	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	752
C7	27	65	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	321
C8	28	65	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	321
C9	29	77	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	21.51
C10	30	77	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	21.51
D1	31	61	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
D2	32	61	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
D3	33	56	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
D4	34	56	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
D5	35	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	554
D6	36	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	554
D7	37	74	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
D8	38	74	F	Bladder	High grade urothelial carcinoma (interstitial)	*	T2bN0M0	II	Malignant	*
D9	39	70	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
D10	40	70	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
E1	41	37	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E2	42	37	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E3	43	67	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	433
E4	44	67	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	433
E5	45	70	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	653
E6	46	70	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	653
E7	47	72	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E8	48	72	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E9	49	45	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	1077
E10	50	45	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	1077
F1	51	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	644
F2	52	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	644
F3	53	67	M	Bladder	High grade urothelial carcinoma (interstitial)	*	T3N0M0	IIIA	Malignant	743
F4	54	67	M	Bladder	High grade urothelial carcinoma (interstitial)	*	T3N0M0	IIIA	Malignant	743
F5	55	67	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
F6	56	67	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
F7	57	65	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	432
F8	58	65	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	432
F9	59	70	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	*
F10	60	70	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	*
G1	61	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	8*7
G2	62	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	8*7
G3	63	45	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
G4	64	45	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
G5	65	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
G6	66	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
G7	67	52	M	Bladder	High grade urothelial carcinoma (sparse)	*	T4aN0M0	IIIA	Malignant	*
G8	68	52	M	Bladder	High grade urothelial carcinoma (sparse)	*	T4aN0M0	IIIA	Malignant	*
G9	69	75	M	Bladder	Squamous cell carcinoma	*	T2N1M0	IIIA	Malignant	*
G10	70	75	M	Bladder	Squamous cell carcinoma	*	T2N1M0	IIIA	Malignant	*
H1	71	66	F	Bladder	Squamous cell carcinoma (grade II)	*	T3N1M0	IIIA	Malignant	*
H2	72	66	F	Bladder	Squamous cell carcinoma (grade II)	*	T3N1M0	IIIA	Malignant	*
H3	73	51	M	Bladder	Squamous cell carcinoma (grade II)	*	T2bN2M0	IIIB	Malignant	*
H4	74	51	M	Bladder	Squamous cell carcinoma (grade II) (sparse)	*	T2bN2M0	IIIB	Malignant	*
H5	75	48	F	Bladder	Adenocarcinoma with degenerate (grade II)	*	T3N0M0	IIIA	Malignant	1063
H6	76	48	F	Bladder	Adenocarcinoma with degenerate (grade II)	*	T3N0M0	IIIA	Malignant	1063
H7	77	70	M	Bladder	Adenocarcinoma (grade II)	*	T3N0M0	IIIA	Malignant	*
H8	78	70	M	Bladder	Adenocarcinoma (grade II)	*	T3N0M0	IIIA	Malignant	*
H9	79	58	M	Bladder	Adenocarcinoma (grade II)	*	T3N1M0	IIIA	Malignant	*
H10	80	58	M	Bladder	Adenocarcinoma (grade II)	*	T3N1M0	IIIA	Malignant	*
I1	81	51	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
I2	82	51	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
I3	83	67	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I4	84	67	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I5	85	40	F	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
I6	86	40	F	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
I7	87	65	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I8	88	65	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I9	89	53	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
I10	90	53	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
J1	91	52	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J2	92	52	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J3	93	63	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J4	94	63	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J5	95	49	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J6	96	49	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J7	97	53	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
J8	98	53	M	Bladder	Adjacent normal bladder tissue	*	*	*	NAT	*
J9	99	68	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J10	100	68	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
_marker_

Find overlapping cases with this tissue array:

UBD1003

File Format: .xlsx

Release Date: 2025-01-17 16:12:32
Download

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma